Tenon Medical Raises $4.3M via Senior Convertible Notes with 20% Discount
Tenon Medical closed a private placement of senior convertible promissory notes with a 20% original issue discount, raising $4.3 million gross. The notes carry a September 11, 2026 maturity and convert after six months at 80% of the three-day VWAP, with proceeds funding expansion and clinical studies.
1. Private Placement Overview
On March 12, 2026, Tenon Medical completed a private placement of senior convertible promissory notes with institutional and high-net-worth investors, generating $4.3 million in gross proceeds. The notes were issued with a 20% original issue discount and carry a stated principal of $4.3 million.
2. Conversion Mechanics
Each note becomes convertible into common stock following its six-month anniversary at a conversion price equal to 80% of the volume-weighted average price over the three trading days prior to conversion, subject to standard adjustment provisions.
3. Use of Proceeds
Tenon plans to deploy net proceeds toward commercial expansion, product development, ongoing clinical studies, working capital needs and general corporate purposes to support growth initiatives in its sacro-pelvic disorder treatment business.
4. Regulatory Status
The notes and any shares issued upon conversion remain unregistered under U.S. securities laws and cannot be offered or sold until proper registration or an applicable exemption is secured; further details will be disclosed in the company’s forthcoming 8-K filing.